Similar articles

• [Antineoplastic chemotherapy for bronchial carcinoma].

  Tanneberger S. Tanneberger S. Arch Geschwulstforsch. 1985;55(1):63-71. Arch Geschwulstforsch. 1985. PMID: 2985017 German.
• A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in complete responders following VAPE induction and late intensification.

  Broder LE, Sridhar KS, Selawry OS, Charyulu KN, Rao RK, Saldana MJ, Donnelly EJ, Raub WA Jr. Broder LE, et al. Am J Clin Oncol. 1994 Dec;17(6):527-37. doi: 10.1097/00000421-199412000-00016. Am J Clin Oncol. 1994. PMID: 7977175 Clinical Trial.
• [Polychemotherapy and radiotherapy for small cell cancer of the lung].

  Linchenko IF, Danil'ian VM. Linchenko IF, et al. Vopr Onkol. 1983;29(9):106-14. Vopr Onkol. 1983. PMID: 6314659 Review. Russian. No abstract available.
• [Clinical study of two chemotherapeutic combinations in the treatment of small-cell bronchogenic carcinoma].

  Dangubić V, Vukov N, Mrda V, Spasić D, Sikimić S, Popvić D, Perunović O, Bjelić R. Dangubić V, et al. Zb Vojnomed Akad. 1983;25:40-4. Zb Vojnomed Akad. 1983. PMID: 6099941 Croatian. No abstract available.
• Current chemotherapy of small cell lung cancer.

  Livingston RB. Livingston RB. Chest. 1986 Apr;89(4 Suppl):258S-263S. doi: 10.1378/chest.89.4_supplement.258s. Chest. 1986. PMID: 3007042 Review.